Dr. Vito De Feo is a Lecturer in AI for Brain and Mental Health, utilizing his dual expertise in information engineering and neuroscience. He has published over 30 papers, achieving an h-index of 10, and has secured £1.3 million in research funding. Dr. De Feo co-founded the Future Health Technology Lab, the Consumer Neuroscience Lab, and the Sleep Lab at the University of Essex, and he is also involved in the BCI lab.
His work includes designing state-dependent neural encoders and decoders with embedded neuromorphic hardware, contributing to the development of novel measures of information transfer in the brain, and investigating the impact of the environment on schizophrenia. He has also studied the effects of neonatal hypoxia–ischemia on sleep and developed protocols to assess consciousness in post-coma patients.
Dr. De Feo has contributed to the field of sleep research, securing £1.1 million from the Wellcome Trust Mental Health Award for a project on circadian rhythms. He is also involved in developing algorithms for nucleosomics-based medical decisions, particularly in breast cancer detection. As a leader, he coordinates a consortium on dementia neurorehabilitation and has played a key role in the University's Covid-19 response. He is an active member of several professional societies, including the British Neuropsychology Society, British Neuroscience Association, and IEEE.
Dr. Vito De Feo is a Lecturer in AI for Brain and Mental Health, utilizing his dual expertise in information engineering and neuroscience. He has published over 30 papers, achieving an h-index of 10, and has secured £1.3 million in research funding. Dr. De Feo co-founded the Future Health Technology Lab, the Consumer Neuroscience Lab, and the Sleep Lab at the University of Essex, and he is also involved in the BCI lab.
His work includes designing state-dependent neural encoders and decoders with embedded neuromorphic hardware, contributing to the development of novel measures of information transfer in the brain, and investigating the impact of the environment on schizophrenia. He has also studied the effects of neonatal hypoxia–ischemia on sleep and developed protocols to assess consciousness in post-coma patients.
Dr. De Feo has contributed to the field of sleep research, securing £1.1 million from the Wellcome Trust Mental Health Award for a project on circadian rhythms. He is also involved in developing algorithms for nucleosomics-based medical decisions, particularly in breast cancer detection. As a leader, he coordinates a consortium on dementia neurorehabilitation and has played a key role in the University's Covid-19 response. He is an active member of several professional societies, including the British Neuropsychology Society, British Neuroscience Association, and IEEE.